NVS News and Press, Novartis AG

2026-06-25 11:33:44 ET Investment Overview The privately held biotech Antares Therapeutics announced yesterday that it had struck a deal with Swiss Pharma giant Novartis AG ( NVS ): to discover, develop and commercialize small molecule therapies against promising b...

2026-06-25 09:36:18 ET So, since my March article "GSK Expanding Fast - Oncology, HIV, And Smart Acquisitions" , GSK's stock price tested the +3σ band formed from the VWAP, $58.80, but then corrected back to $51.10.... Read the full article on Seeking Alpha For furthe...

2026-06-24 22:05:00 ET The following segment was excerpted from the TCW Relative Value Large Cap Fund Q1 2026 Commentary. ... Read the full article on Seeking Alpha For further details see: TCW Relative Value Large Cap Fund Q1 2026 Buys A...

2026-06-24 17:11:34 ET Today, I am putting BioAge Labs ( BIOA ) in the spotlight for the first time on these pages. Consistent revenue growth is projected to be years away, but the company has a huge cash hoard that will fund all operations for many years as management executes agai...

2026-06-24 10:06:26 ET More on Novartis Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside Novartis AG (NVS) Q1 2026 Earnings Call Transcript Novartis: Revenue Lags In Q1, Outlook Unchanged Novartis muscle disease therapy succeeds in e...

2026-06-24 09:08:33 ET Since my February article , " Vertex Pharmaceuticals Stock: Is The Bull Run Over, " Vertex Pharmaceuticals Incorporated ( VRTX ) shares have declined by as much as 12%, hitting a low of $412.9 on May 5, before rallying to the +1σ band formed fro...

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the globe are currently living w...

2026-06-23 12:55:55 ET So, since my October comparison article , " Teva Vs. Viatris: Who Will Dominate In President Trump's America? ," Viatris Inc.'s ( VTRS ) shares have risen 54.1%, outperforming Sandoz Group [45.3% return] ( SDZNY ), its key competitor in the generic...

2026-06-22 10:33:59 ET At the end of April, I published an article , " Merck: Bullish Setup Into Q1 Earnings, " in which I initially aimed to present the factors that would lead Merck & Co., Inc. ( MRK ) to once again show strong numbers.... Read the full article o...

2026-06-19 08:56:00 ET Teva Pharmaceuticals (NYSE: TEVA) is morphing from a generic drug maker into one that develops more innovative -- and profitable -- drugs. The stock is up more than 10% this year, and more than 95% over the past year. On June 8, the company released data r...